Twist Bioscience Corp (NASDAQ:TWST)
| 20.56 Delayed Data As of 4:00pm ET |  +0.69 / +3.47%Today’s Change | 11.46 Today|||52-Week Range 40.50 | -13.65% Year-to-Date |
Latest TWST News | Press Releases
| Twist Bioscience Corp (TWST): A Deep Dive into Its Performance Potential Sep 26 / GuruFocus News - Paid Partner Content | Twist Bioscience (TWST) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards Sep 26 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 19.87 |
| Today’s open | 21.00 |
| Day’s range | 20.08 - 21.34 |
| Volume | 64,342 |
| Average volume (3 months) | 1,128,375 |
| Market cap | $1.2B |
Data as of 4:00pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -28.26% |
| Earnings growth (this year) | +1.71% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +53.83% |
| P/E ratio | NM |
| Price/Sales | 9.33 |
| Price/Book | 1.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | +0.01 | +0.46% |
| ARVNArvinas Inc | -0.47 | -2.25% |
| IOVAIovance Biotherapeut... | +0.06 | +1.35% |
| AUPHAurinia Pharmaceutic... | -0.19 | -2.33% |
Data as of 4:00pm ET, 09/27/2023
Financials
| Next reporting date | December 20, 2023 |
| EPS forecast (this quarter) | -$1.02 |
| Annual revenue (last year) | $203.6M |
| Annual profit (last year) | -$217.9M |
| Net profit margin | -107.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
